• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, February 7, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Inducing labor can help prevent cesarean births

Bioengineer by Bioengineer
August 8, 2018
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

GALVESTON, Texas — A new national study has found that inducing labor in first-time mothers at 39 weeks can help prevent cesarean births and high blood pressure.

The University of Texas Medical Branch participated in the study and Dr. George Saade, chief of obstetrics and the principal investigator at UTMB, said that babies born to women induced at 39 weeks did not have worse outcomes compared to those who were not induced at 39 weeks.

"Actually, they had lower respiratory problems," Saade said. "This is the first large trial ever done on this topic and its result will have a significant impact on the management of pregnancy because it goes against the belief that induction would increase cesarean and lead to worse outcomes."

The study, published in the New England Journal of Medicine, was conducted through the Maternal-Fetal Medicine Units Network, which is supported by the National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development.

"First time mothers now should discuss this with their health care provider and decide whether they prefer to be induced at 39 weeks or wait for labor to start on its own," Saade said. "At UTMB, we have already made changes to our practice in order to address this new approach and the likely need for more induction of labor."

The study involved more than 6,100 healthy, first-time expectant mothers at UTMB and 11 other clinical centers across the U.S. About half of the women were randomly assigned to be induced at 39 weeks, while the other half waited for labor to begin naturally. Some women in the latter group were induced after 39 weeks for medical reasons.

While delivering by cesarean section is generally safe for mother and baby, it is a surgical procedure with potential risks and a longer recovery time.

"Nationally, the rates of cesarean births remain high," Saade said. "Most pregnancies after the first cesarean are delivered by cesarean again. So preventing the first cesarean is one of the most effective ways to decrease overall cesarean rates. We hope that this new study will lead to some significant decreases in cesarean rates nationally. We also hope that rates of hypertension in pregnancy, a condition that can lead to severe complications and even death, will decrease too."

###

Media Contact

Raul Reyes
[email protected]
409-747-0794
@utmbnews

http://www.utmb.edu

http://www.utmb.edu/newsroom/article11832.aspx

Share12Tweet7Share2ShareShareShare1

Related Posts

Neg-Entropy: The Key Therapeutic Target for Chronic Diseases

February 7, 2026

Multidisciplinary Evidence-Based Guidelines for Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease

February 7, 2026

Early Tuberculosis Treatment Lowers Sepsis Mortality in People with HIV

February 7, 2026

Structure-Guided Development of Picomolar Macrocyclic Inhibitors Targeting TRPC5 Channels with Antidepressant Effects

February 7, 2026
Please login to join discussion

POPULAR NEWS

  • Robotic Ureteral Reconstruction: A Novel Approach

    Robotic Ureteral Reconstruction: A Novel Approach

    82 shares
    Share 33 Tweet 21
  • Digital Privacy: Health Data Control in Incarceration

    63 shares
    Share 25 Tweet 16
  • Study Reveals Lipid Accumulation in ME/CFS Cells

    57 shares
    Share 23 Tweet 14
  • Breakthrough in RNA Research Accelerates Medical Innovations Timeline

    53 shares
    Share 21 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Neg-Entropy: The Key Therapeutic Target for Chronic Diseases

Multidisciplinary Evidence-Based Guidelines for Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease

Early Tuberculosis Treatment Lowers Sepsis Mortality in People with HIV

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 73 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.